tirzepatide deaths linked to lower risk for death, adverse CV and kidney outcomes vs. GLP-1s 🚨 New real-world data from

Injecting into a Bruise or Scar: Never inject into skin that is already irritated, bruised, scarred, or tender

Contact us to start with a free CPT 20610 denial audit

Cascinu S, Catalano V, Cordella L, et al

Important safety considerations include avoidance in uncontrolled asthma and acute iritis, and cautious use in patients receiving concomitant -blocker therapy

In Phase 2 trial data (Rosenstock et al., NEJM 2023), participants with type 2 diabetes showed meaningful improvements in HbA1c within the first eight weeks

Punitive damages: Available if discovery shows that a manufacturer delayed or concealed known safety risks